Cibus Stock (NASDAQ: CBUS) stock price, news, charts, stock research, profile.
Open | $18.000 |
Close | $17.770 |
Volume / Avg. | 62.573K / 67.173K |
Day Range | 17.561 - 18.730 |
52 Wk Range | 8.900 - 32.710 |
Market Cap | $438.702M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 3.14% |
Days to Cover | 6.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cibus (NASDAQ: CBUS) through any online brokerage.
Other companies in Cibus’s space includes: Zura Bio (NASDAQ:ZURA), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Replimune Group (NASDAQ:REPL).
The latest price target for Cibus (NASDAQ: CBUS) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 25.00 expecting CBUS to rise to within 12 months (a possible 40.69% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cibus (NASDAQ: CBUS) is $17.77 last updated Today at May 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Cibus.
Cibus’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Cibus.
Cibus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.